Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Cai, Hui"" wg kryterium: Autor


Tytuł :
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.
Autorzy :
Liu J; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
Prager-van der Smissen WJC; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Collée JM; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Biostatistics Unit, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.; Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Ahearn TU; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
Aittomäki K; Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Ambrosone CB; Roswell Park Cancer Institute, Buffalo, NY, USA.
Andrulis IL; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Anton-Culver H; Department of Epidemiology, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, CA, USA.
Antonenkova NN; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
Arndt V; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Arnold N; Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.; Institute of Clinical Molecular Biology, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.
Aronson KJ; Department of Public Health Sciences, and Cancer Research Institute, Queen's University, Kingston, ON, Canada.
Augustinsson A; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
Auvinen P; Cancer Center, Kuopio University Hospital, Kuopio, Finland.; Institute of Clinical Medicine, Oncology, University of Eastern Finland, Kuopio, Finland.; Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.
Becher H; Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Institute of Biometry and Clinical Epidemiology, Charité -Universitätsmedizin Berlin, Berlin, Germany.
Beckmann MW; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
Behrens S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Bermisheva M; Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.
Bernstein L; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
Bogdanova NV; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Bogdanova-Markov N; Institute of Human Genetics, University of Münster, Münster, Germany.
Bojesen SE; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Brauch H; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; iFIT-Cluster of Excellence, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.
Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Briceno I; Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia.; Medical Faculty, Universidad de La Sabana, Bogota, Colombia.
Brucker SY; Department of Gynecology and Obstetrics, University of Tübingen, Tübingen, Germany.
Brüning T; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany.
Burwinkel B; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, Heidelberg, Germany.
Cai Q; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Cai H; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Campa D; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Biology, University of Pisa, Pisa, Italy.
Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Castelao JE; Oncology and Genetics Unit, Instituto de Investigacion Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
Choi JY; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea.
Christiaens M; Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Clarke CL; Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Daly MB; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
Devilee P; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Dos-Santos-Silva I; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Dwek M; School of Life Sciences, University of Westminster, London, UK.
Eccles DM; Faculty of Medicine, University of Southampton, Southampton, UK.
Eliassen AH; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Fasching PA; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA.
Figueroa J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.; Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.; Cancer Research UK Edinburgh Centre, The University of Edinburgh, Edinburgh, UK.
Flyger H; Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
Fritschi L; School of Public Health, Curtin University, Perth, Western Australia, Australia.
Gago-Dominguez M; Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
Gapstur SM; Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, USA.
García-Closas M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.
García-Sáenz JA; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Gaudet MM; Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, USA.
Giles GG; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
Goldberg MS; Department of Medicine, McGill University, Montréal, QC, Canada.; Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montréal, QC, Canada.
Goldgar DE; Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
Guénel P; Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.
Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Håkansson N; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology, Södersjukhuset, Stockholm, Sweden.
Harrington PA; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Hart SN; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Hartman M; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore.; Department of Surgery, National University Health System, Singapore, Singapore.
Hillemanns P; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
Hou MF; Department of Surgery, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan.
Hunter DJ; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Huo D; Center for Clinical Cancer Genetics, The University of Chicago, Chicago, IL, USA.
Ito H; Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.; Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Iwasaki M; Division of Epidemiology, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Jakimovska M; Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', MASA, Skopje, Republic of North Macedonia.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland.
John EM; Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Kang D; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea.; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Keeman R; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Khusnutdinova E; Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.; Saint Petersburg State University, Saint-Petersburg, Russia.
Kim SW; Department of Surgery, Daerim Saint Mary's Hospital, Seoul, Korea.
Kraft P; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Kristensen VN; Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
Kurian AW; Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA.
Le Marchand L; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.
Li J; Human Genetics Division, Genome Institute of Singapore, Singapore, Singapore.
Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
Lophatananon A; Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Luben RN; Clinical Gerontology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Lubiński J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Mannermaa A; Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
Manoochehri M; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Manoukian S; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Margolin S; Department of Oncology, Södersjukhuset, Stockholm, Sweden.; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
Mariapun S; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Matsuo K; Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.; Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Maurer T; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Mavroudis D; Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece.
Meindl A; Department of Gynecology and Obstetrics, University of Munich, Campus Großhadern, Munich, Germany.
Menon U; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London, UK.
Milne RL; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
Muir K; Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Mulligan AM; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.
Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Offit K; Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Olopade OI; Center for Clinical Cancer Genetics, The University of Chicago, Chicago, IL, USA.
Olson JE; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Olsson H; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
Orr N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Ireland, UK.
Park SK; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea.; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Peterlongo P; Genome Diagnostics Program, IFOM - the FIRC Institute for Molecular Oncology, Milan, Italy.
Peto J; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Plaseska-Karanfilska D; Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', MASA, Skopje, Republic of North Macedonia.
Presneau N; School of Life Sciences, University of Westminster, London, UK.
Rack B; Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
Rau-Murthy R; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Rennert G; Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Rennert HS; Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Rhenius V; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Romero A; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.
Ruebner M; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Saloustros E; Department of Oncology, University Hospital of Larissa, Larissa, Greece.
Schmutzler RK; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Schneeweiss A; Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases, University Hospital and German Cancer Research Center, Heidelberg, Germany.
Scott C; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Shen CY; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.; School of Public Health, China Medical University, Taichung, Taiwan.
Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Simard J; Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Québec City, QC, Canada.
Sohn C; National Center for Tumor Diseases, University Hospital and German Cancer Research Center, Heidelberg, Germany.
Southey MC; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia.
Spinelli JJ; Population Oncology, BC Cancer, Vancouver, BC, Canada.; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Tamimi RM; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Tapper WJ; Faculty of Medicine, University of Southampton, Southampton, UK.
Teo SH; Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Terry MB; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
Torres D; Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia.; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Truong T; Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.
Untch M; Department of Gynecology and Obstetrics, Helios Clinics Berlin-Buch, Berlin, Germany.
Vachon CM; Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA.
van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Wolk A; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Yamaji T; Division of Epidemiology, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Ziogas A; Department of Epidemiology, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, CA, USA.
Ziv E; Department of Medicine, Institute for Human Genetics, UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
Torres-Mejía G; Center for Population Health Research, National Institute of Public Health, Cuernavaca, Morelos, Mexico.
Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Swerdlow AJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Schmidt MK; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Pharoah PDP; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Hooning MJ; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Martens JWM; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Hollestelle A; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. .
Pokaż więcej
Corporate Authors :
NBCS Collaborators
ABCTB Investigators
Źródło :
Scientific reports [Sci Rep] 2020 Jun 16; Vol. 10 (1), pp. 9688. Date of Electronic Publication: 2020 Jun 16.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Breast Neoplasms/*genetics
Germ-Line Mutation/*genetics
Homeodomain Proteins/*genetics
Female ; Genetic Predisposition to Disease/genetics ; Genotyping Techniques ; Humans ; Middle Aged ; Risk Factors
Czasopismo naukowe
Tytuł :
Accelerated aging in breast cancer survivors and its association with mortality and cancer recurrence.
Autorzy :
Zhu J; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 600 (IMPH), Nashville, TN, USA.
Wang F; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 600 (IMPH), Nashville, TN, USA.; Department of Breast Surgery, The Second Hospital of Shandong University, Jinan, Shandong, People's Republic of China.
Shi L; Department of Chronic Non-Communicable Disease Surveillance, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, People's Republic of China.
Cai H; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 600 (IMPH), Nashville, TN, USA.
Zheng Y; Department of Cancer Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, People's Republic of China.; Department of Cancer Prevention, Shanghai Cancer Center, Fudan University, Shanghai, People's Republic of China.
Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 600 (IMPH), Nashville, TN, USA.
Bao P; Department of Chronic Non-Communicable Disease Surveillance, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, People's Republic of China.
Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 600 (IMPH), Nashville, TN, USA. .
Pokaż więcej
Źródło :
Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Apr; Vol. 180 (2), pp. 449-459. Date of Electronic Publication: 2020 Feb 04.
Typ publikacji :
Journal Article
MeSH Terms :
Quality of Life*
Aging/*pathology
Breast Neoplasms/*mortality
Cancer Survivors/*psychology
Neoplasm Recurrence, Local/*mortality
Activities of Daily Living/psychology ; Adult ; Aged ; Breast Neoplasms/pathology ; Breast Neoplasms/psychology ; Cancer Survivors/statistics & numerical data ; Depression/pathology ; Fatigue/pathology ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/psychology ; Prospective Studies ; Risk Factors ; Sleep Initiation and Maintenance Disorders/pathology ; Survival Rate ; Young Adult
Czasopismo naukowe
Tytuł :
Adherence to Dietary Recommendations among Long-Term Breast Cancer Survivors and Cancer Outcome Associations.
Autorzy :
Wang F; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Breast Surgery, the Second Hospital of Shandong University, Jinan, Shandong, China.
Cai H; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Gu K; Department of Cancer Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Shi L; Department of Cancer Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Yu D; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Zhang M; Department of Cancer Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Zheng Y; Department of Cancer Prevention, Shanghai Cancer Center, Fudan University, Shanghai, China.
Bao P; Department of Cancer Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. .
Pokaż więcej
Źródło :
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2020 Feb; Vol. 29 (2), pp. 386-395. Date of Electronic Publication: 2019 Dec 23.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Feeding Behavior*
Breast Neoplasms/*mortality
Cancer Survivors/*statistics & numerical data
Diet Surveys/*statistics & numerical data
Neoplasm Recurrence, Local/*epidemiology
Patient Compliance/*statistics & numerical data
Adult ; Aged ; Breast Neoplasms/diagnosis ; Breast Neoplasms/therapy ; China/epidemiology ; Female ; Follow-Up Studies ; Guidelines as Topic ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Neoplasm Recurrence, Local/prevention & control ; Prognosis ; Prospective Studies ; Risk Factors ; Risk Reduction Behavior
Czasopismo naukowe
Tytuł :
Use of Antihypertensive Medications and Survival Rates for Breast, Colorectal, Lung, or Stomach Cancer.
Autorzy :
Cui Y; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Wen W; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Zheng T; Tongren Hospital, Shanghai Jiao Tong University, Shanghai, China.
Li H; State Key Laboratory of Oncogene and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.; Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Gao YT; State Key Laboratory of Oncogene and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.; Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Cai H; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
You M; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Gao J; State Key Laboratory of Oncogene and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.; Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Yang G; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Xiang YB; State Key Laboratory of Oncogene and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.; Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Pokaż więcej
Źródło :
American journal of epidemiology [Am J Epidemiol] 2019 Aug 01; Vol. 188 (8), pp. 1512-1528.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Antihypertensive Agents/*therapeutic use
Breast Neoplasms/*mortality
Colorectal Neoplasms/*mortality
Lung Neoplasms/*mortality
Stomach Neoplasms/*mortality
Adult ; Aged ; China/epidemiology ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Registries ; Risk Factors ; Survival Rate
Czasopismo naukowe
Tytuł :
Associations of dietary intake and supplement use with post-therapy cognitive recovery in breast cancer survivors.
Autorzy :
Huang Z; Division of Non-communicable Disease and Injury, Shanghai Municipal Center for Disease Control and Prevention, 1380 Zhongshan West Road, 200336, Shanghai, China.
Shi Y; Division of Non-communicable Disease and Injury, Shanghai Municipal Center for Disease Control and Prevention, 1380 Zhongshan West Road, 200336, Shanghai, China. .
Bao P; Division of Non-communicable Disease and Injury, Shanghai Municipal Center for Disease Control and Prevention, 1380 Zhongshan West Road, 200336, Shanghai, China.
Cai H; Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, 37203-1738, USA.
Hong Z; Department of Neurology, Huashan Hospital, Fudan University, 200040, Shanghai, China.
Ding D; Department of Neurology, Huashan Hospital, Fudan University, 200040, Shanghai, China.
Jackson J; Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, 37203-1738, USA.
Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, 37203-1738, USA.
Dai Q; Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, 37203-1738, USA.
Pokaż więcej
Źródło :
Breast cancer research and treatment [Breast Cancer Res Treat] 2018 Aug; Vol. 171 (1), pp. 189-198. Date of Electronic Publication: 2018 May 09.
Typ publikacji :
Journal Article
MeSH Terms :
Dietary Supplements*
Breast Neoplasms/*psychology
Breast Neoplasms/*rehabilitation
Cancer Survivors/*psychology
Cognition/*drug effects
Adult ; Aged ; Breast Neoplasms/therapy ; Female ; Humans ; Middle Aged ; Risk Factors ; Time Factors ; Young Adult
Czasopismo naukowe
Tytuł :
Time-varying effects of prognostic factors associated with long-term survival in breast cancer.
Autorzy :
Zhang M; Department of Cancer Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, People's Republic of China.; Department of Biostatistics, School of Public Health and Key Lab of Health Technology Assessment, National Health and Family Planning Commission of the People's Republic of China, Fudan University, Shanghai, People's Republic of China.
Peng P; Department of Cancer Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, People's Republic of China.
Gu K; Department of Cancer Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, People's Republic of China.
Cai H; Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Qin G; Department of Biostatistics, School of Public Health and Key Lab of Health Technology Assessment, National Health and Family Planning Commission of the People's Republic of China, Fudan University, Shanghai, People's Republic of China.; Collaborative Innovation Center of Social Risks Governance in Health, Fudan University, Shanghai, People's Republic of China.
Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Bao P; Department of Cancer Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, People's Republic of China.
Pokaż więcej
Źródło :
Endocrine-related cancer [Endocr Relat Cancer] 2018 May; Vol. 25 (5), pp. 509-521. Date of Electronic Publication: 2018 Feb 22.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Breast Neoplasms/*mortality
Cancer Survivors/*psychology
Adult ; Aged ; Breast Neoplasms/pathology ; Female ; Humans ; Middle Aged ; Prognosis ; Young Adult
Czasopismo naukowe
Tytuł :
Association analysis identifies 65 new breast cancer risk loci.
Autorzy :
Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
Lindström S; Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA.; Program in Genetic Epidemiology and Statistical Genetics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Beesley J; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Hui S; The Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
Kar S; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Lemaçon A; Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Quebec, Canada.
Soucy P; Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Quebec, Canada.
Glubb D; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Rostamianfar A; The Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Tyrer J; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Dicks E; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Lee A; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Wang Z; Department of Computational Biology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.; Cancer Genomics Research Laboratory (CGR), Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Allen J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Keeman R; Division of Molecular Pathology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Eilber U; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
French JD; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Qing Chen X; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Fachal L; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
McCue K; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
McCart Reed AE; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia.
Ghoussaini M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Carroll JS; Cancer Research UK Cambridge Research Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
Jiang X; Program in Genetic Epidemiology and Statistical Genetics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Finucane H; Program in Genetic Epidemiology and Statistical Genetics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Mathematics, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Adams M; Center for Inherited Disease Research (CIDR), Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Adank MA; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
Ahsan H; Center for Cancer Epidemiology and Prevention, The University of Chicago, Chicago, Illinois, USA.
Aittomäki K; Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Anton-Culver H; Department of Epidemiology, University of California Irvine, Irvine, California, USA.
Antonenkova NN; N. N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
Arndt V; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Aronson KJ; Department of Public Health Sciences, and Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.
Arun B; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Auer PL; Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Bacot F; McGill University and Génome Québec Innovation Centre, Montréal, Quebec, Canada.
Barrdahl M; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Baynes C; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Beckmann MW; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Behrens S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Benitez J; Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain.; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain.
Bermisheva M; Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, Ufa, Russia.
Bernstein L; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA.
Blomqvist C; Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Bogdanova NV; N. N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Bojesen SE; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Bonanni B; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy.
Børresen-Dale AL; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
Brand JS; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Brauch H; Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Brennan P; International Agency for Research on Cancer, Lyon, France.
Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Brinton L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Broberg P; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
Brock IW; Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
Broeks A; Division of Molecular Pathology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Brooks-Wilson A; Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada.; Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada.
Brucker SY; Department of Gynecology and Obstetrics, University of Tübingen, Tübingen, Germany.
Brüning T; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum, Bochum, Germany.
Burwinkel B; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Butterbach K; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Cai Q; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Cai H; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Caldés T; Medical Oncology Department, Hospital Clínico San Carlos, IdISSC (Centro Investigacion Biomedica en Red), CIBERONC (Instituto de Investigación Sanitaria San Carlos), Madrid, Spain.
Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Carracedo A; Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago De Compostela, Spain.; Centro de Investigación en Red de Enfermedades Raras (CIBERER) y Centro Nacional de Genotipado (CEGEN-PRB2), Universidad de Santiago de Compostela, Santiago De Compostela, Spain.
Carter BD; Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA.
Castelao JE; Oncology and Genetics Unit, Instituto de Investigacion Biomedica (IBI) Orense-Pontevedra-Vigo, Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.
Chan TL; Hong Kong Hereditary Breast Cancer Family Registry, Happy Valley, Hong Kong.; Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.
David Cheng TY; Division of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York, USA.
Seng Chia K; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
Choi JY; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, South Korea.; Cancer Research Institute, Seoul National University, Seoul, South Korea.
Christiansen H; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
Clarke CL; Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
Collée M; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Conroy DM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Cordina-Duverger E; Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.
Cornelissen S; Division of Molecular Pathology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Cox DG; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.; INSERM U1052, Cancer Research Center of Lyon, Lyon, France.
Cox A; Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
Cross SS; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK.
Cunningham JM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Daly MB; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Devilee P; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Doheny KF; Center for Inherited Disease Research (CIDR), Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Dos-Santos-Silva I; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Dumont M; Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Quebec, Canada.
Durcan L; Southampton Clinical Trials Unit, Faculty of Medicine, University of Southampton, Southampton, UK.; Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
Dwek M; Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK.
Eccles DM; Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
Ekici AB; Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Eliassen AH; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Ellberg C; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.; Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Elvira M; Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, Russia.
Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.; LIFE-Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Eriksson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Fasching PA; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California, USA.
Figueroa J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.; Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh, UK.
Flesch-Janys D; Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Fletcher O; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Flyger H; Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
Fritschi L; School of Public Health, Curtin University, Perth, Australia.
Gaborieau V; International Agency for Research on Cancer, Lyon, France.
Gabrielson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Gago-Dominguez M; Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago De Compostela, Spain.; Moores Cancer Center, University of California San Diego, La Jolla, California, USA.
Gao YT; Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China.
Gapstur SM; Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA.
García-Sáenz JA; Medical Oncology Department, Hospital Clínico San Carlos, IdISSC (Centro Investigacion Biomedica en Red), CIBERONC (Instituto de Investigación Sanitaria San Carlos), Madrid, Spain.
Gaudet MM; Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA.
Georgoulias V; Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece.
Giles GG; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Glendon G; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
Goldberg MS; Department of Medicine, McGill University, Montréal, Quebec, Canada.; Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montréal, Quebec, Canada.
Goldgar DE; Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA.
González-Neira A; Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain.
Grenaker Alnæs GI; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
Grip M; Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland.
Gronwald J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Grundy A; Centre de Recherche du Centre Hospitalier de Université de Montréal (CHUM), Université de Montréal, Montréal, Quebec, Canada.
Guénel P; Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.
Haeberle L; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Hahnen E; Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Håkansson N; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Hamel N; McGill University and Génome Québec Innovation Centre, Montréal, Quebec, Canada.
Hankinson S; Department of Biostatistics & Epidemiology, University of Massachusetts, Amherst, Amherst, Massachusetts, USA.
Harrington P; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Hart SN; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Hartikainen JM; Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
Hartman M; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.; Department of Surgery, National University Health System, Singapore, Singapore.
Hein A; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Heyworth J; School of Population Health, University of Western Australia, Perth, Australia.
Hicks B; Cancer Genomics Research Laboratory (CGR), Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Hillemanns P; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Ho DN; Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.
Hollestelle A; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Hooning MJ; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Hoover RN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Hou MF; Division of Breast Surgery, Department of Surgery, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hsiung CN; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Huang G; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Humphreys K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Ishiguro J; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.; Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ito H; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.; Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Iwasaki M; Division of Epidemiology, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Janni W; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
John EM; Department of Epidemiology, Cancer Prevention Institute of California, Fremont, California, USA.; Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
Johnson N; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Jones K; Cancer Genomics Research Laboratory (CGR), Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Jones M; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Jukkola-Vuorinen A; Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland.
Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Kabisch M; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Kaczmarek K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Kang D; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, South Korea.; Cancer Research Institute, Seoul National University, Seoul, South Korea.; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Kasuga Y; Department of Surgery, Nagano Matsushiro General Hospital, Nagano, Japan.
Kerin MJ; School of Medicine, National University of Ireland, Galway, Ireland.
Khan S; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Khusnutdinova E; Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, Ufa, Russia.; Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, Russia.
Kiiski JI; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Kim SW; Department of Surgery, Daerim Saint Mary's Hospital, Seoul, South Korea.
Knight JA; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Kosma VM; Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
Kristensen VN; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway.
Krüger U; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
Kwong A; Hong Kong Hereditary Breast Cancer Family Registry, Happy Valley, Hong Kong.; Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong.; Department of Surgery, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.
Lambrechts D; Vesalius Research Center, VIB, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
Le Marchand L; University of Hawaii Cancer Center, Honolulu, Hawaii, USA.
Lee E; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Lee MH; Department of Surgery, Soonchunhyang University College of Medicine and Soonchunhyang University Hospital, Seoul, South Korea.
Lee JW; Department of Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, South Korea.
Neng Lee C; Department of Surgery, National University Health System, Singapore, Singapore.; Department of Cardiac, Thoracic and Vascular Surgery, National University Health System, Singapore, Singapore.
Lejbkowicz F; Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Li J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Lilyquist J; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Lissowska J; Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center & Institute of Oncology, Warsaw, Poland.
Lo WY; Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tübingen, Tübingen, Germany.
Loibl S; German Breast Group GmbH, Neu Isenburg, Germany.
Long J; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Lophatananon A; Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, UK.; Institute of Population Health, University of Manchester, Manchester, UK.
Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Luccarini C; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Lux MP; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Ma ESK; Hong Kong Hereditary Breast Cancer Family Registry, Happy Valley, Hong Kong.; Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.
MacInnis RJ; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Maishman T; Southampton Clinical Trials Unit, Faculty of Medicine, University of Southampton, Southampton, UK.; Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
Makalic E; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Malone KE; Division of Public Health Sciences, Epidemiology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Kostovska IM; Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Macedonian Academy of Sciences and Arts, Skopje, Republic of Macedonia.
Mannermaa A; Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
Manoukian S; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy.
Manson JE; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Margolin S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Mariapun S; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Martinez ME; Moores Cancer Center, University of California San Diego, La Jolla, California, USA.; Department of Family Medicine and Public Health, University of California San Diego, La Jolla, California, USA.
Matsuo K; Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.
Mavroudis D; Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece.
McKay J; International Agency for Research on Cancer, Lyon, France.
McLean C; Anatomical Pathology, The Alfred Hospital, Melbourne, Australia.
Meijers-Heijboer H; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
Meindl A; Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany.
Menéndez P; Servicio de Anatomía Patológica, Hospital Monte Naranco, Oviedo, Spain.
Menon U; Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, UK.
Meyer J; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Miao H; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
Miller N; School of Medicine, National University of Ireland, Galway, Ireland.
Taib NAM; Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Muir K; Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, UK.; Institute of Population Health, University of Manchester, Manchester, UK.
Mulligan AM; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
Mulot C; Université Paris Sorbonne Cité, INSERM UMR-S1147, Paris, France.
Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California, USA.
Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Neven P; Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Nielsen SF; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
Noh DY; Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea.
Nordestgaard BG; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Norman A; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Olopade OI; Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, Illinois, USA.
Olson JE; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Olsson H; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
Olswold C; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Orr N; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Pankratz VS; University of New Mexico Health Sciences Center, University of New Mexico, Albuquerque, New Mexico, USA.
Park SK; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, South Korea.; Cancer Research Institute, Seoul National University, Seoul, South Korea.; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea.
Park-Simon TW; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Lloyd R; The Curtin UWA Centre for Genetic Origins of Health and Disease, Curtin University and University of Western Australia, Perth, Australia.
Perez JIA; Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain.
Peterlongo P; IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy.
Peto J; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Phillips KA; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.; Peter MacCallum Cancer Center, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Department of Medicine, St Vincent's Hospital, The University of Melbourne, Fitzroy, Australia.
Pinchev M; Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Plaseska-Karanfilska D; Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Macedonian Academy of Sciences and Arts, Skopje, Republic of Macedonia.
Prentice R; Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Presneau N; Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK.
Prokofyeva D; Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, Russia.
Pugh E; Center for Inherited Disease Research (CIDR), Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Pylkäs K; Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.; Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland.
Rack B; Department of Gynecology and Obstetrics, Ludwig-Maximilians University of Munich, Munich, Germany.
Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy.
Rahman N; Section of Cancer Genetics, The Institute of Cancer Research, London, UK.
Rennert G; Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Rennert HS; Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
Rhenius V; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Romero A; Medical Oncology Department, Hospital Clínico San Carlos, IdISSC (Centro Investigacion Biomedica en Red), CIBERONC (Instituto de Investigación Sanitaria San Carlos), Madrid, Spain.; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.
Romm J; Center for Inherited Disease Research (CIDR), Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Ruddy KJ; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Rüdiger T; Institute of Pathology, Staedtisches Klinikum Karlsruhe, Karlsruhe, Germany.
Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Ruebner M; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Rutgers EJT; Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Saloustros E; Hereditary Cancer Clinic, University Hospital of Heraklion, Heraklion, Greece.
Sandler DP; Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina, USA.
Sangrajrang S; National Cancer Institute, Bangkok, Thailand.
Sawyer EJ; Research Oncology, Guy's Hospital, King's College London, London, UK.
Schmidt DF; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Schmutzler RK; Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Schneeweiss A; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
Schoemaker MJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Schumacher F; Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio, USA.
Schürmann P; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Scott RJ; Division of Molecular Medicine, Pathology North, John Hunter Hospital, Newcastle, Australia.; Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, Australia.
Scott C; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Seal S; Section of Cancer Genetics, The Institute of Cancer Research, London, UK.
Seynaeve C; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Sharma P; Department of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
Shen CY; School of Public Health, China Medical University, Taichung, Taiwan.; Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Sheng G; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Sherman ME; Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland, USA.
Shrubsole MJ; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Smeets A; Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Sohn C; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
Southey MC; Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, Australia.
Spinelli JJ; Cancer Control Research, BC Cancer Agency, Vancouver, British Columbia, Canada.; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Stegmaier C; Saarland Cancer Registry, Saarbrücken, Germany.
Stewart-Brown S; Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, UK.
Stone J; The Curtin UWA Centre for Genetic Origins of Health and Disease, Curtin University and University of Western Australia, Perth, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne and the Royal Women's Hospital, Melbourne, Australia.
Stram DO; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Surowy H; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Swerdlow A; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
Tamimi R; Program in Genetic Epidemiology and Statistical Genetics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Taylor JA; Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina, USA.; Epigenetic and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina, USA.
Tengström M; Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.; Cancer Center, Kuopio University Hospital, Kuopio, Finland.; Institute of Clinical Medicine, Oncology, University of Eastern Finland, Kuopio, Finland.
Teo SH; Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.; Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Beth Terry M; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA.
Tessier DC; McGill University and Génome Québec Innovation Centre, Montréal, Quebec, Canada.
Thanasitthichai S; National Cancer Institute, Ministry of Public Health, Nonthaburi, Thailand.
Thöne K; Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Tollenaar RAEM; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Tomlinson I; Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
Tong L; Center for Cancer Epidemiology and Prevention, The University of Chicago, Chicago, Illinois, USA.
Torres D; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia.
Truong T; Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.
Tseng CC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Tsugane S; Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Ulmer HU; Frauenklinik der Stadtklinik Baden-Baden, Baden-Baden, Germany.
Ursin G; Cancer Registry of Norway, Oslo, Norway.; Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Untch M; Department of Gynecology and Obstetrics, Helios Clinics Berlin-Buch, Berlin, Germany.
Vachon C; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Van Den Berg D; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
van den Ouweland AMW; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
van der Kolk L; Family Cancer Clinic, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
van der Luijt RB; Division of Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Vincent D; McGill University and Génome Québec Innovation Centre, Montréal, Quebec, Canada.
Vollenweider J; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Waisfisz Q; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands.
Wang-Gohrke S; Department of Gynaecology and Obstetrics, University of Ulm, Ulm, Germany.
Weinberg CR; Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina, USA.
Wendt C; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Whittemore AS; Department of Health Research and Policy-Epidemiology, Stanford University School of Medicine, Stanford, California, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
Wildiers H; Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Willett W; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.; Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland.
Wolk A; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Xia L; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Yamaji T; Division of Epidemiology, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Yang XR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Har Yip C; Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia.
Yoo KY; Seoul National University College of Medicine, Seoul, South Korea.; Armed Forces Capital Hospital, Seongnam, South Korea.
Yu JC; Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Zheng Y; Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Zhu B; Cancer Genomics Research Laboratory (CGR), Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Ziogas A; Department of Epidemiology, University of California Irvine, Irvine, California, USA.
Ziv E; Department of Medicine, Institute for Human Genetics, UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
Lakhani SR; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia.; Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane 4029, Australia.
Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Droit A; Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Quebec, Canada.
Andrulis IL; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Amos CI; Center for Genomic Medicine, Department of Biomedical Data Science, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire, USA.
Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Pharoah PDP; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology, Södersjukhuset, Stockholm, Sweden.
Hunter DJ; Program in Genetic Epidemiology and Statistical Genetics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Milne RL; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
García-Closas M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Schmidt MK; Division of Molecular Pathology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Edwards SL; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Bader GD; The Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
Chenevix-Trench G; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Simard J; Genomics Center, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Quebec, Canada.
Kraft P; Program in Genetic Epidemiology and Statistical Genetics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Pokaż więcej
Corporate Authors :
NBCS Collaborators
ABCTB Investigators
ConFab/AOCS Investigators
Źródło :
Nature [Nature] 2017 Nov 02; Vol. 551 (7678), pp. 92-94. Date of Electronic Publication: 2017 Oct 23.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Genetic Loci*
Genome-Wide Association Study*
Breast Neoplasms/*genetics
Genetic Predisposition to Disease/*genetics
Asia/ethnology ; Asian Continental Ancestry Group/genetics ; Binding Sites/genetics ; Breast Neoplasms/diagnosis ; Computer Simulation ; Europe/ethnology ; European Continental Ancestry Group/genetics ; Female ; Humans ; Multifactorial Inheritance/genetics ; Polymorphism, Single Nucleotide/genetics ; Regulatory Sequences, Nucleic Acid ; Risk Assessment ; Transcription Factors/metabolism
Czasopismo naukowe
Tytuł :
Body mass index, waist-to-hip ratio and late outcomes: a report from the Shanghai Breast Cancer Survival Study.
Autorzy :
Zhang M; Department of Biostatistics, School of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, People's Republic of China.; Department of Cancer Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, People's Republic of China.
Cai H; Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, USA.
Bao P; Department of Chronic Non-Communicable Disease Surveillance, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, People's Republic of China.
Xu W; Department of Epidemiology, School of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, People's Republic of China.
Qin G; Department of Biostatistics, School of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, People's Republic of China. .; Collaborative Innovation Center of Social Risks Governance in Health, Fudan University, Shanghai, People's Republic of China. .
Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, USA.
Zheng Y; Department of Cancer Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, People's Republic of China. .; Department of Cancer Prevention, Shanghai Cancer Center, Fudan University, Shanghai, People's Republic of China. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2017 Aug 01; Vol. 7 (1), pp. 6996. Date of Electronic Publication: 2017 Aug 01.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Breast Neoplasms/*complications
Breast Neoplasms/*pathology
Obesity/*complications
Aged ; Body Mass Index ; Breast Neoplasms/mortality ; Female ; Humans ; Longitudinal Studies ; Middle Aged ; Obesity/mortality ; Recurrence ; Risk Assessment ; Survival Analysis ; Treatment Outcome ; Waist-Hip Ratio
Czasopismo naukowe
Tytuł :
Aging, obesity, and post-therapy cognitive recovery in breast cancer survivors.
Autorzy :
Huang Z; Department of Elderly Health, Division of Noncommunicable Disease and Injury, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Zheng Y; Department of Cancer Control and Prevention, Division of Noncommunicable Disease and Injury, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Bao P; Department of Noncommunicable Disease Surveillance, Division of Noncommunicable Disease and Injury, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Cai H; Department of Medicine, Division of Epidemiology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Hong Z; Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Ding D; Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Jackson J; Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Shu XO; Department of Medicine, Division of Epidemiology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Dai Q; Department of Medicine, Division of Epidemiology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2017 Feb 14; Vol. 8 (7), pp. 12364-12373.
Typ publikacji :
Journal Article
MeSH Terms :
Aging/*physiology
Breast Neoplasms/*physiopathology
Cognition/*physiology
Obesity/*physiopathology
Survivors/*statistics & numerical data
Adult ; Age Factors ; Aged ; Body Mass Index ; Breast Neoplasms/psychology ; Breast Neoplasms/therapy ; Cognition Disorders/physiopathology ; Cognition Disorders/psychology ; Exercise/physiology ; Female ; Humans ; Linear Models ; Memory/physiology ; Middle Aged ; Surveys and Questionnaires ; Waist-Hip Ratio ; Young Adult
Czasopismo naukowe
Tytuł :
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
Autorzy :
Southey MC; Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, Australia.
Goldgar DE; Huntsman Cancer Institute, Salt Lake City, UT, USA.
Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit and Biocenter Oulu, University of Oulu, Nordlab Oulu, Oulu, Finland.
Pylkäs K; Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit and Biocenter Oulu, University of Oulu, Nordlab Oulu, Oulu, Finland.
Couch F; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Tischkowitz M; Department of Medical Genetics and National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, and the Department of Clinical Genetics, East Anglian Regional Genetics Service, Addenbrooke's Hospital.
Foulkes WD; Program in Cancer Genetics, Department of Human Genetics and Oncology, Lady Davis Institute, and Research Institute, McGill University Health Centre, McGill University, Montreal, Canada.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Laboratory, Worts Causeway, Cambridge, UK.
Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Laboratory, Worts Causeway, Cambridge, UK.
van Rensburg EJ; Department of Genetics, University of Pretoria, South Africa.
Heikkinen T; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Hopper JL; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Claes KB; Center for Medical Genetics, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium.
Reis-Filho J; Department of Pathology and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Teo ZL; Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, Australia.
Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
Catucci I; IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Peterlongo P; IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Tsimiklis H; Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, Australia.
Odefrey FA; Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, Australia.
Dowty JG; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
Schmidt MK; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
Broeks A; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
Hogervorst FB; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
Verhoef S; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
Carpenter J; Australian Breast Cancer Tissue Bank, University of Sydney at the Westmead Institute for Medical Research, NSW, Australia.
Clarke C; Centre for Cancer Research, University of Sydney at the Westmead Institute for Medical Research, NSW, Australia.
Scott RJ; Division of Molecular Medicine, Pathology North, Newcastle and University of Newcastle, NSW, Australia.
Fasching PA; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, CA, USA.
Haeberle L; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.; Unit of Biostatistics, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Ekici AB; Institute of Human Genetics, University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Beckmann MW; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
Peto J; Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, UK.
Dos-Santos-Silva I; Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, UK.
Fletcher O; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
Johnson N; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Laboratory, Worts Causeway, Cambridge, UK.
Sawyer EJ; Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London, London, UK.
Tomlinson I; Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, UK and Oxford NIHR Biomedical Research Centre, Headington, OX3 7LE.
Kerin MJ; Surgery, Lambe Institute for Translational Science, NUIGalway, University Hospital Galway, Galway, Ireland.
Miller N; Surgery, Lambe Institute for Translational Science, NUIGalway, University Hospital Galway, Galway, Ireland.
Marme F; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
Burwinkel B; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Yang R; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Guénel P; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France.; University Paris-Sud, UMRS 1018, Villejuif, France.
Truong T; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France.; University Paris-Sud, UMRS 1018, Villejuif, France.
Menegaux F; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France.; University Paris-Sud, UMRS 1018, Villejuif, France.
Sanchez M; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France.; University Paris-Sud, UMRS 1018, Villejuif, France.
Bojesen S; Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
Nielsen SF; Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
Flyger H; Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
Benitez J; Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain.
Zamora MP; Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain.
Perez JI; Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain.
Menéndez P; Servicio de Anatomía Patológica, Hospital Monte Naranco, Oviedo, Spain.
Anton-Culver H; Department of Epidemiology, University of California Irvine, Irvine, California, USA.
Neuhausen S; Beckman Research Institute of City of Hope, Duarte, California, USA.
Ziogas A; Department of Epidemiology, University of California Irvine, Irvine, California, USA.
Clarke CA; Cancer Prevention Institute of California, Fremont, California, USA.
Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Arndt V; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Stegmaier C; Saarland Cancer Registry, Saarbrücken, Germany.
Brauch H; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart.; University of Tübingen, Tübingen, Germany.
Brüning T; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University, Bochum (IPA), Germany.
Ko YD; Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany.
Muranen TA; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Aittomäki K; Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland.
Blomqvist C; Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland.
Bogdanova NV; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
Antonenkova NN; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Margolin S; Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden.
Mannermaa A; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, and Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
Kataja V; School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, Kuopio, Finland.; Biocenter Kuopio, Cancer Center of Eastern Finland, Kuopio University Hospital, Kuopio, Finland.
Kosma VM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, and Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
Hartikainen JM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, and Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
Spurdle AB; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Investigators K; Research Department, Peter MacCallum Cancer Centre and The Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia.
Wauters E; Vesalius Research Center (VRC), VIB, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
Smeets D; Vesalius Research Center (VRC), VIB, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
Beuselinck B; University Hospital Gasthuisberg, Leuven, Belgium.
Floris G; University Hospital Gasthuisberg, Leuven, Belgium.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Seibold P; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Flesch-Janys D; Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany.
Olson JE; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Vachon C; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Pankratz VS; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
McLean C; Anatomical Pathology, The Alfred Hospital, Melbourne, Australia.
Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Henderson BE; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Schumacher F; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Le Marchand L; Epidemiology Program, Cancer Research Center, University of Hawaii, Honolulu, HI, USA.
Kristensen V; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.; Faculty of Medicine (Faculty Division Ahus), University of Oslo (UiO), Norway.
Alnæs GG; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.
Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Hunter DJ; Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, MA, USA.; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
Lindstrom S; Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, MA, USA.; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
Hankinson SE; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.; Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Kraft P; Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, MA, USA.; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
Andrulis I; Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Knight JA; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Glendon G; Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
Mulligan AM; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.; Laboratory Medicine Program, University Health Network, Toronto, Ontario; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Jukkola-Vuorinen A; Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland.
Grip M; Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland.
Kauppila S; Department of Pathology, Oulu University Hospital, University of Oulu, Oulu, Finland.
Devilee P; Department of Surgical Oncology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Tollenaar RA; Department of Surgical Oncology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Seynaeve C; Family Cancer Clinic, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands.; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Hollestelle A; Family Cancer Clinic, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands.; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Garcia-Closas M; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK.
Figueroa J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
Lissowska J; Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center & Institute of Oncology, Warsaw, Poland.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden.
Darabi H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden.
Eriksson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden.
Eccles DM; Faculty of Medicine, University of Southampton (UoS), Southampton UK.
Rafiq S; Faculty of Medicine, University of Southampton (UoS), Southampton UK.
Tapper WJ; Faculty of Medicine, University of Southampton (UoS), Southampton UK.
Gerty SM; Faculty of Medicine, University of Southampton (UoS), Southampton UK.
Hooning MJ; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Martens JW; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Collée JM; Department of Clinical Genetics, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands.
Tilanus-Linthorst M; Department of Surgical Oncology, Family Cancer Clinic, Erasmus University Medical Center, Rotterdam, The Netherlands.
Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden.
Li J; Human Genetics Division, Genome Institute of Singapore, Singapore 138672, Singapore.
Brand JS; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden.
Humphreys K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden.
Cox A; Sheffield Cancer Research, Department of Oncology, University of Sheffield, Sheffield, UK.
Reed MW; Sheffield Cancer Research, Department of Oncology, University of Sheffield, Sheffield, UK.
Luccarini C; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Baynes C; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Torres D; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia.
Ulmer HU; Frauenklinik der Stadtklinik Baden-Baden, Baden-Baden, Germany.
Rüdiger T; Institute of Pathology, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Jaworska K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.; Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland.
Durda K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Slager S; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Toland AE; Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Ambrosone CB; Roswell Park Cancer Institute, Buffalo, New York, USA.
Yannoukakos D; Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, Athens, Greece.
Swerdlow A; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.; Division of Breast Cancer Research, Institute of Cancer Research, London, UK.
Ashworth A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK.
Orr N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK.
Jones M; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK.
González-Neira A; Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Pita G; Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Alonso MR; Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Álvarez N; Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Herrero D; Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Tessier DC; Centre d'innovation Genome Quebec et University McGill Montreal Quebec, Canada.
Vincent D; McGill University, Montreal, Quebec, Canada.
Bacot F; McGill University, Montreal, Quebec, Canada.
Simard J; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Quebec Research Center. Laval University, Quebec, Canada.
Dumont M; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Quebec Research Center. Laval University, Quebec, Canada.
Soucy P; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Quebec Research Center. Laval University, Quebec, Canada.
Eeles R; The Institute of Cancer Research, London, SM2 5NG, UK.; Royal Marsden NHS Foundation Trust, Fulham, London, SW3 6JJ, UK.
Muir K; University of Warwick, Coventry, UK.
Wiklund F; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Gronberg H; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
Schleutker J; Department of Medical Biochemistry and Genetics, University of Turku, and Tyks Microbiology and Genetics, Department of Medical Genetics, Turku University Hospital, Turku, Finland.; Institute of Biomedical Technology/BioMediTech, University of Tampere, Tampere, Finland.
Nordestgaard BG; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev Ringvej 75, DK-2730 Herlev, Denmark.
Weischer M; Department of Human Genetics University of Utah, Salt Lake City, UT, USA and Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
Travis RC; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Neal D; Surgical Oncology (Uro-Oncology: S4), University of Cambridge, Box 279, Addenbrooke's Hospital, Hills Road, Cambridge, UK and Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK.
Donovan JL; Professor of Social Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS.
Hamdy FC; Nuffield Department of Surgical Sciences, Old Road Campus Research Building (off Roosevelt Drive), University of Oxford, Headington, Oxford, OX3 7DQ.
Khaw KT; Cambridge Institute of Public Health, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 0SR.
Stanford JL; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA.
Blot WJ; International Epidemiology Institute, 1455 Research Blvd., Suite 550, Rockville, MD 20850.
Thibodeau S; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Schaid DJ; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Kelley JL; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Maier C; Department of Urology, University Hospital Ulm, Germany.; Institute of Human Genetics University Hospital Ulm, Germany.
Kibel AS; Brigham and Women's Hospital/Dana-Farber Cancer Institute, 45 Francis Street- ASB II-3, Boston, MA 02115.; Washington University, St Louis, Missouri.
Cybulski C; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Cannon-Albright L; Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine.
Butterbach K; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Park J; Division of Cancer Prevention and Control, H. Lee Moffitt Cancer Center, 12902 Magnolia Dr., Tampa, Florida, USA.
Kaneva R; Molecular Medicine Center and Department of Medical Chemistry and Biochemistry, Medical University - Sofia, 2 Zdrave St, 1431, Sofia, Bulgaria.
Batra J; Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and Schools of Life Science and Public Health, Queensland University of Technology, Brisbane, Australia.
Teixeira MR; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal and Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal.
Kote-Jarai Z; The Institute of Cancer Research, London, SM2 5NG, UK.
Olama AA; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Laboratory, Worts Causeway, Cambridge, UK.
Benlloch S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Laboratory, Worts Causeway, Cambridge, UK.
Renner SP; University Hospital Erlangen, Department of Gynecology and Obstetrics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.
Hartmann A; University Hospital Erlangen, Institute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Universitaetsstrasse 21-23, 91054 Erlangen, German.
Hein A; University Hospital Erlangen, Department of Gynecology and Obstetrics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.
Ruebner M; University Hospital Erlangen, Department of Gynecology and Obstetrics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Universitaetsstrasse 21-23, 91054 Erlangen, Germany.
Lambrechts D; Vesalius Research Center, VIB, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Belgium.
Van Nieuwenhuysen E; Department of Epidemiology, The Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Vergote I; Department of Epidemiology, The Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Lambretchs S; Department of Epidemiology, The Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Doherty JA; Department of Epidemiology, The Geisel School of Medicine at Dartmouth, Hannover, NH, USA.
Rossing MA; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Epidemiology, University of Washington, Seattle, WA, USA.
Nickels S; German Cancer Research Center, Division of Cancer Epidemiology, Heidelberg, Germany.
Eilber U; German Cancer Research Center, Division of Cancer Epidemiology, Heidelberg, Germany.
Wang-Gohrke S; Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany.
Odunsi K; Department of Gynecological Oncology, Roswell Park Cancer Institute, Buffalo, NY.
Sucheston-Campbell LE; Department of Gynecological Oncology, Roswell Park Cancer Institute, Buffalo, NY.
Friel G; Department of Gynecological Oncology, Roswell Park Cancer Institute, Buffalo, NY.
Lurie G; Cancer Epidemiology Program, University of Hawaii Cancer Center, Hawaii, USA.
Killeen JL; Department of Pathology, Kapiolani Medical Center for Women and Children, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii 96826, USA.
Wilkens LR; Cancer Epidemiology Program, University of Hawaii Cancer Center, Hawaii, USA.
Goodman MT; Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.; Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Runnebaum I; Department of Gynecology and Obstetrics, Friedrich Schiller University, Jena University Hospital, Jena, Germany.
Hillemanns PA; Clinics of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany.
Pelttari LM; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Butzow R; Department of Pathology, Helsinki University Central Hospital, Helsinki, 00029 HUS, Finland.
Modugno F; University of Pittsburgh Department of Obstetrics, Gynecology and Reproductive Sciences and Ovarian Cancer Center of Excellence Pittsburgh PA USA.; University of Pittsburgh Department of Epidemiology, University of Pittsburgh Graduate School of Public Health and Womens Cancer Research Program, Magee-Womens Research Institute and University of Pittsburgh Cancer Institute Pittsburgh PA USA.
Edwards RP; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Ness RB; The University of Texas School of Public Health, Houston, TX, USA.
Moysich KB; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY.
du Bois A; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/ Knappschaft GmbH, Essen, Germany.; Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
Heitz F; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/ Knappschaft GmbH, Essen, Germany.; Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
Harter P; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/ Evang. Huyssens-Stiftung/ Knappschaft GmbH, Essen, Germany.; Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
Kommoss S; Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.; Tuebingen University Hospital, Department of Women's Health, Tuebingen, Germany.
Karlan BY; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Walsh C; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Lester J; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Jensen A; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
Kjaer SK; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.; Department of Obstetrics and Gynecology, Rigshospitalet, Copenhagen, Denmark.
Høgdall E; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.; Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
Peissel B; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
Bonanni B; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), Milan, Italy.
Bernard L; Department of Experimental Oncology, Istituto Europeo di Oncologia (IEO), Milan, Italy and Cogentech Cancer Genetic Test Laboratory, Milan, Italy.
Goode EL; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Fridley BL; University of Kansas Medical Center, Kansas City, KS, USA.
Vierkant RA; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Cunningham JM; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Larson MC; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Fogarty ZC; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Kalli KR; Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Liang D; College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas, USA.
Lu KH; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Hildebrandt MA; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Wu X; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Levine DA; Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Dao F; Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Bisogna M; Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Berchuck A; Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina, USA.
Iversen ES; Department of Statistical Science, Duke University, Durham, North Carolina, USA.
Marks JR; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
Akushevich L; Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina, USA.
Cramer DW; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Schildkraut J; Cancer Prevention, Detection & Control Research Program, Duke Cancer Institute, Durham, North Carolina, USA.
Terry KL; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Poole EM; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School.; Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, Massachusetts, USA.
Stampfer M; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School.
Tworoger SS; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School.; Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, Massachusetts, USA.
Bandera EV; Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, The State University of New Jersey, New Brunswick, NJ, USA.
Orlow I; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Olson SH; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Bjorge L; Department of Gynecology and Obstetrics, Haukeland University Horpital, Bergen, Norway.; Centre for Cancer Biomarkers, Department of Clinical Sciences, University of Bergen, Bergen, Norway.
Salvesen HB; Department of Gynecology and Obstetrics, Haukeland University Horpital, Bergen, Norway.; Centre for Cancer Biomarkers, Department of Clinical Sciences, University of Bergen, Bergen, Norway.
van Altena AM; Radboud university medical center, Department of Gynaecology, Nijmegen, Netherlands.
Aben KK; Radboud university medical centre, Radboud Institute for Health Sciences, Nijmegen, Netherlands.; Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.; Department of Obstetrcs & Gynecology, Oregon Health & Science University.
Kiemeney LA; Radboud university medical centre, Radboud Institute for Health Sciences, Nijmegen, Netherlands.
Massuger LF; Radboud university medical center, Department of Gynaecology, Nijmegen, Netherlands.
Pejovic T; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.
Bean Y; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.
Brooks-Wilson A; Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada.; Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC Canada.
Kelemen LE; Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, SC, USA.; Hollings Cancer Center, Medical University of South Carolina, SC, USA.
Cook LS; Division of Epidemiology and Biostatistics, Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico, USA.
Le ND; Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada.
Górski B; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Gronwald J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Menkiszak J; Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents, Pomeranian Medical University, Szczecin, Poland.
Høgdall CK; Department of Obstetrics and Gynecology, Rigshospitalet, Copenhagen, Denmark.
Lundvall L; Gyn Clinic, Rigshospitalet, University of Copenhagen, Denmark.
Nedergaard L; Department of Pathology, Rigshospitalet, University of Copenhagen, Denmark.
Engelholm SA; Department of Oncology, Rigshospitalet, University of Copenhagen, Denmark.
Dicks E; Department of Oncology, University of Cambridge, Strangeways Research laboratory, Cambridge, UK.
Tyrer J; Department of Oncology, University of Cambridge, Strangeways Research laboratory, Cambridge, UK.
Campbell I; Cancer Genetics Laboratory, Research Division, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne.
McNeish I; Institute of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Beatson Institute for Cancer Research, Glasgow, UK.
Paul J; The Cancer Research UK Clinical Trials Unit, Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow, G12 0YN.
Siddiqui N; Department of Gynaecological Oncology, Glasgow Royal Infirmary.
Glasspool R; Department of Gynaecological Oncology, Glasgow Royal Infirmary.
Whittemore AS; Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford CA, USA.
Rothstein JH; Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford CA, USA.
McGuire V; Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford CA, USA.
Sieh W; Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford CA, USA.
Cai H; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Teten RT; Epidemiology Center, College of Medicine, University of South Florida, Tampa, Florida, USA.
Sutphen R; Epidemiology Center, College of Medicine, University of South Florida, Tampa, Florida, USA.
McLaughlin JR; Public Health Ontario, Toronto, Canada.
Narod SA; Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
Phelan CM; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
Monteiro AN; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
Fenstermacher D; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
Lin HY; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
Permuth JB; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
Sellers TA; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
Chen YA; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
Tsai YY; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
Chen Z; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
Gentry-Maharaj A; Women's Cancer, Institute for Women's Health, UCL, London, United Kingdom.
Gayther SA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Ramus SJ; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Menon U; Women's Cancer, Institute for Women's Health, UCL, London, United Kingdom.
Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Pearce CL; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Van Den Berg D; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Pike MC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Dansonka-Mieszkowska A; Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Plisiecka-Halasa J; Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Moes-Sosnowska J; Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Kupryjanczyk J; Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Pharoah PD; Department of Oncology, University of Cambridge, Strangeways Research laboratory, Cambridge, UK.
Song H; Department of Oncology, University of Cambridge, Strangeways Research laboratory, Cambridge, UK.
Winship I; Department of Medicine, The University of Melbourne Health, Australia.; The Royal Melbourne Hospital, Victoria 3050, Australia.
Chenevix-Trench G; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Giles GG; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia.; Cancer Epidemiology Centre, Cancer Council Victoria, Victoria, Australia.
Tavtigian SV; Huntsman Cancer Institute, Salt Lake City, UT, USA.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Laboratory, Worts Causeway, Cambridge, UK.
Milne RL; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Australia.; Cancer Epidemiology Centre, Cancer Council Victoria, Victoria, Australia.
Pokaż więcej
Corporate Authors :
Australian Ovarian Cancer Study Group
Źródło :
Journal of medical genetics [J Med Genet] 2016 Dec; Vol. 53 (12), pp. 800-811. Date of Electronic Publication: 2016 Sep 05.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't
MeSH Terms :
Genetic Predisposition to Disease*
Mutation*
Ataxia Telangiectasia Mutated Proteins/*genetics
Breast Neoplasms/*metabolism
Checkpoint Kinase 2/*genetics
Nuclear Proteins/*genetics
Prostatic Neoplasms/*metabolism
Tumor Suppressor Proteins/*genetics
Breast Neoplasms/epidemiology ; Breast Neoplasms/genetics ; Case-Control Studies ; Fanconi Anemia Complementation Group N Protein ; Female ; Genetic Association Studies ; Humans ; Male ; Ovarian Neoplasms/epidemiology ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/metabolism ; Prostatic Neoplasms/epidemiology ; Prostatic Neoplasms/genetics ; Risk
Czasopismo naukowe
Tytuł :
Associations of the Transforming Growth Factor β/Smad Pathway, Body Mass Index, and Physical Activity With Breast Cancer Outcomes: Results From the Shanghai Breast Cancer Study.
Autorzy :
Su Y
Cai H
Zheng Y
Qiu Q
Lu W
Shu XO
Cai Q
Pokaż więcej
Źródło :
American journal of epidemiology [Am J Epidemiol] 2016 Oct 01; Vol. 184 (7), pp. 501-509. Date of Electronic Publication: 2016 Sep 19.
Typ publikacji :
Journal Article
MeSH Terms :
Body Mass Index*
Breast Neoplasms/*metabolism
Exercise/*physiology
Protein-Serine-Threonine Kinases/*metabolism
Receptors, Transforming Growth Factor beta/*metabolism
Smad2 Protein/*metabolism
Adult ; Biomarkers, Tumor/metabolism ; Breast Neoplasms/mortality ; Breast Neoplasms/physiopathology ; Cell Nucleus/metabolism ; China ; Disease Progression ; Disease-Free Survival ; Female ; Humans ; Middle Aged ; Prognosis ; Proportional Hazards Models ; Receptor, Transforming Growth Factor-beta Type II ; Signal Transduction/physiology
Czasopismo naukowe
Tytuł :
Roles of LPA receptor signaling in breast cancer.
Autorzy :
Wang J; a The Second Department of Thoracic Surgery , The First Affiliated Hospital of Xi'an Jiaotong University , Xi'an , P.R. China.
Sun Y; b Department of Radiation Oncology , The First Affiliated Hospital of Xi'an Jiaotong University , Xi'an , P.R. China.
Qu J; a The Second Department of Thoracic Surgery , The First Affiliated Hospital of Xi'an Jiaotong University , Xi'an , P.R. China.
Yan Y; a The Second Department of Thoracic Surgery , The First Affiliated Hospital of Xi'an Jiaotong University , Xi'an , P.R. China.
Yang Y; c Department iii of Radiation Oncology, 2 Comprehensive Thermal Therapy Center , The First Affiliated Hospital of Zhengzhou University , Zhengzhou , P.R. China.
Cai H; d The Department of Vascular Surgery , The First Affiliated Hospital of Xi'an Jiaotong University , Xi'an , P.R. China.
Pokaż więcej
Źródło :
Expert review of molecular diagnostics [Expert Rev Mol Diagn] 2016 Oct; Vol. 16 (10), pp. 1103-1111. Date of Electronic Publication: 2016 Sep 28.
Typ publikacji :
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms :
Signal Transduction*
Breast Neoplasms/*metabolism
Receptors, Lysophosphatidic Acid/*metabolism
Animals ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Biomarkers ; Breast Neoplasms/drug therapy ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Cell Movement ; Cell Proliferation ; Cell Transformation, Neoplastic/genetics ; Cell Transformation, Neoplastic/metabolism ; Disease Progression ; Drug Resistance, Neoplasm ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Lysophospholipids/biosynthesis ; Phosphoric Diester Hydrolases/metabolism ; Receptors, Lysophosphatidic Acid/antagonists & inhibitors ; Receptors, Lysophosphatidic Acid/genetics ; Transcriptome
Czasopismo naukowe
Tytuł :
Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer.
Autorzy :
Shi J; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.
Zhang Y; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.
Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.
Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
Ghoussaini M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Lush M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Milne RL; Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria 3053, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global health, The University of Melbourne, Melbourne, Victoria 3053, Australia.
Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.
Beesley J; Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Kar S; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Andrulis IL; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, M5G 1X5, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON, M5S 1A8, Canada.
Anton-Culver H; Department of Epidemiology, University of California Irvine, Irvine, CA 92697, USA.
Arndt V; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg 69120, Germany.
Beckmann MW; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen 91054, Germany.
Zhao Z; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.
Guo X; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.
Benitez J; Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid 28029, Spain.; Centro de Investigación en Red de Enfermedades Raras, Valencia, Spain.
Beeghly-Fadiel A; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.
Blot W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.; International Epidemiology Institute, Rockville, MD 20850, USA.
Bogdanova NV; Department of Radiation Oncology, Hannover Medical School, Hannover 30625, Germany.
Bojesen SE; Copenhagen General Population Study, Herlev Hospital, 2730 Herlev, Denmark.; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Brauch H; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart 70376, Germany.; University of Tübingen, Tübingen 72074, Germany.; German Cancer Consortium, German Cancer Research Center(DKFZ), Heidelberg 69120, Germany.
Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg 69120, Germany.; German Cancer Consortium, German Cancer Research Center(DKFZ), Heidelberg 69120, Germany.; Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
Brinton L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20850, USA.
Broeks A; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam 1066 CX, The Netherlands.
Brüning T; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Bochum 44789, Germany.
Burwinkel B; Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg 69120, Germany.; Molecular Epidemiology Group, German Cancer Research Center, Heidelberg 69120, Germany.
Cai H; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.
Canisius S; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, the Netherlands.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg 69120, Germany.
Choi JY; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 110-799, Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea.
Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
Cox A; Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield S10 2RX, UK.
Cross SS; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield S10 2HQ, UK.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm SE-17177, Sweden.
Darabi H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm SE-17177, Sweden.
Devilee P; Separtment of Pathology, Leiden University Medical Center, Leiden 2333 ZC, The Netherlands.; Department of Human Genetics, Leiden University Medical Center, Leiden 2333 ZC, The Netherlands.
Droit A; Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City G1V 4G2, Canada.
Dork T; Gynaecology Research Unit, Hannover Medical School, Hannover 30625, Germany.
Fasching PA; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen 91054, Germany.; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Fletcher O; Division of Cancer Studies, Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London SW3 6JB, UK.
Flyger H; Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.
Fostira F; Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research 'Demokritos', 153 10 Athens, Greece.
Gaborieau V; International Agency for Research on Cancer, Lyon 69372, France.
García-Closas M; Division of Cancer Studies, Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London SW3 6JB, UK.; Division of Genetics and Epidemiology, Institute of Cancer Research, London SW7 3RP, UK.
Giles GG; Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Victoria 3053, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global health, The University of Melbourne, Melbourne, Victoria 3053, Australia.
Guenel P; Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif 94807, France.; University Paris-Sud, Villejuif 94807, France.
Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
Hartman M; Saw Swee Hock School of Public Health, National University of Singapore, Singapore 119077, Singapore.; Department of Surgery, National University Health System, Singapore 117597.
Miao H; Saw Swee Hock School of Public Health, National University of Singapore, Singapore 119077, Singapore.
Hollestelle A; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 CN Rotterdam, The Netherlands.
Hopper JL; Division of Gynaecology and Obstetrics, Technische Universität München, Munich 81675, Germany.
Hsiung CN; Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
Ito H; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Aichi 464-8681, Japan.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin 70-115, Poland.
Johnson N; Division of Cancer Studies, Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London SW3 6JB, UK.
Torres D; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.; Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota 12362, Colombi.
Kabisch M; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
Kang D; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 110-799, Korea.; Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea.; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, FI-00029 HUS, Finland.
Khan S; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, FI-00029 HUS, Finland.
Knight JA; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, M5G 1X5, Canada.; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, M5S 1A8, Canada.
Kosma VM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finlan.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio 70210, Finland.
Lambrechts D; Vesalius Research Center, Leuven 3000, Belgium.; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven 3000, Belgium.
Li J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm SE-17177, Sweden.
Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm SE-17177, Sweden.
Lophatananon A; Division of Health Sciences, Warwick Medical School, Warwick University, Coventry CV4 7AL, UK.
Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin 70-115, Poland.
Mannermaa A; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finlan.; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio 70210, Finland.
Manoukian S; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan 20133, Italy.
Le Marchand L; University of Hawaii Cancer Center, Honolulu, HI 96813, USA.
Margolin S; Department of Oncology - Pathology, Karolinska Institutet, Stockholm SE-17177, Sweden.
Marme F; National Center for Tumor Diseases, University of Heidelberg, Heidelberg 69120, Germany.; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg 69120, Germany.
Matsuo K; Department of Preventive Medicine, Kyushu University Faculty of Medical Sciences, Fukuoka, Japan.
McLean C; Anatomical Pathology, The Alfred Hospital, Melbourne, , Victoria 3004, Australia.
Meindl A; Division of Gynaecology and Obstetrics, Technische Universität München, Munich 81675, Germany.
Muir K; Division of Health Sciences, Warwick Medical School, Warwick University, Coventry CV4 7AL, UK.; Institute of Population Health, University of Manchester, Manchester M13 9PL, UK.
Neuhausen SL; Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.
Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, FI-00029 HUS, Finland.
Nord S; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Ullernchausseen 70, N-0310 Oslo, Norway.; K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway.
Børresen-Dale AL; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Ullernchausseen 70, N-0310 Oslo, Norway.; K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway.
Olson JE; Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
Orr N; Division of Breast Cancer Research, Institute of Cancer Research, London, UK; Cancer Research, Institute of Cancer Research, London SW3 6JB, UK.
van den Ouweland AMW; Department of Clinical Genetics, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
Peterlongo P; IFOM, the FIRC Institute of Molecular Oncology, Milan 20139, Italy.
Putti TC; Department of Pathology, National University Health System, Singapore 117597.
Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg 69120, Germany.
Sangrajrang S; National Cancer Institute, Bangkok 10400, Thailand.
Sawyer EJ; Research Oncology, Guy's Hospital, King's College London, London SE1 9RT, UK.
Schmidt MK; Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam 1066 CX, The Netherlands.
Schmutzler RK; Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, Cologne 50931, Germany.; Center for Integrated Oncology, University Hospital of Cologne, Cologne 50931, Germany.; Center for Molecular Medicine, University Hospital of Cologne, Cologne 50931, Germany.; Center of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne 50931, Germany.
Shen CY; School of Public Health, China Medical University, Taichung 404, Taiwan.; Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
Hou MF; Cancer Center and Department of Surgery, Chung-Ho Memorial Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Shrubsole MJ; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.
Southey MC; Department of Pathology, The University of Melbourne, Melbourne, Victoria 3010, Australia.
Swerdlow A; Division of Genetics and Epidemiology and Division of Breast Cancer Research, Institute of Cancer Research, London SW7 3RP, UK.
Teo SH; Cancer Research Initiatives Foundation, 47500 Subang Jaya, Selangor, Malaysia.; Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre, 59100 KualaLumpur, Malaysia.
Thienpont B; Vesalius Research Center, Leuven 3000, Belgium.; Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven 3000, Belgium.
Toland AE; Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
Tollenaar RAEM; Department of Surgical Oncology, Leiden University Medical Center, 2333 ZC Leiden, The Netherlands.
Tomlinson I; Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Oxford OX3 7BN, UK.
Truong T; Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif 94807, France.; University Paris-Sud, Villejuif 94807, France.
Tseng CC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Wen W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.
Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry, University of Oulu, Oulu FI-90220, Finland.; Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre NordLab, Oulu FI-90220, Finland.
Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Yip CH; Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre, 59100 KualaLumpur, Malaysia.
Zamora PM; Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid 28046, Spain.
Zheng Y; Shanghai Municipal Center for Disease Control and Prevention, Shanghai, 200336, PR China.
Floris G; University Hospital Gashuisberg, Leuven, Belgium.
Cheng CY; Singapore Eye Research Institute, National University of Singapore, Singapore, Singapore.
Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 CN Rotterdam, The Netherlands.
Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 CN Rotterdam, The Netherlands.
Seynaeve C; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 CN Rotterdam, The Netherlands.
Kristensen VN; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Ullernchausseen 70, N-0310 Oslo, Norway.; K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway.; Department of Clinical Molecular Biology (EpiGen), Akershus University Hospital, University of Oslo (UiO), Oslo, Norway.
Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm SE-17177, Sweden.
Pharoah PDP; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Simard J; Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City G1V 4G2, Canada.
Chenevix-Trench G; Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Peter MacCallum Cancer Centre, The University of Melbourne, East Melbourne, VIC 3002, Australi.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
Cai Q; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.
Long J; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37203, USA.
Pokaż więcej
Corporate Authors :
Mervi Grip
kConFab Investigators
Źródło :
International journal of cancer [Int J Cancer] 2016 Sep 15; Vol. 139 (6), pp. 1303-1317. Date of Electronic Publication: 2016 Jun 17.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Chromosome Mapping*
Genetic Variation*
Quantitative Trait Loci*
Breast Neoplasms/*epidemiology
Breast Neoplasms/*genetics
Chromosomes, Human, Pair 8/*genetics
Alleles ; Case-Control Studies ; European Continental Ancestry Group/genetics ; Female ; Genome-Wide Association Study ; Genotype ; Haplotypes ; Humans ; Linkage Disequilibrium ; Odds Ratio ; Polymorphism, Single Nucleotide ; Risk
Czasopismo naukowe
Tytuł :
Perichondrium mesenchymal stem cells inhibit the growth of breast cancer cells via the DKK-1/Wnt/β-catenin signaling pathway.
Autorzy :
Li M; The Second Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Cai H; Department of Vascular Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Yang Y; The Third Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, P.R. China.
Zhang J; The Second Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Sun K; Department of Medical Oncology, The Second Hospital of Lanzhou, Lanzhou, Gansu 730000, P.R. China.
Yan Y; The Second Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Qu H; The Second Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Wang W; Department of Histology and Embryology, Laboratory of Stem Cell and Tissue Engineering, Chongqing Medical University, Chongqing 400016, P.R. China.
Wang J; The Second Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Duan X; Department of Radiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
Pokaż więcej
Źródło :
Oncology reports [Oncol Rep] 2016 Aug; Vol. 36 (2), pp. 936-44. Date of Electronic Publication: 2016 Jun 03.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms/*genetics
Breast Neoplasms/*pathology
Cell Proliferation/*genetics
Intercellular Signaling Peptides and Proteins/*genetics
Mesenchymal Stem Cells/*pathology
Wnt Signaling Pathway/*genetics
Animals ; Breast Neoplasms/metabolism ; Cell Differentiation/genetics ; Cell Line, Tumor ; Cell Movement/genetics ; Culture Media, Conditioned/metabolism ; Down-Regulation/genetics ; Female ; Gene Expression Regulation, Neoplastic/genetics ; Mesenchymal Stem Cells/metabolism ; Neoplasm Invasiveness/genetics ; Rats ; Rats, Sprague-Dawley
Czasopismo naukowe
Tytuł :
A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor-positive breast cancer prognosis.
Autorzy :
Nechuta S; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center; and Vanderbilt-Ingram Cancer Center, Vanderbilt School of Medicine, Nashville, TN.
Chen WY; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA.
Cai H; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center; and Vanderbilt-Ingram Cancer Center, Vanderbilt School of Medicine, Nashville, TN.
Poole EM; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Kwan ML; Division of Research, Kaiser Permanente Northern California, Oakland, CA.
Flatt SW; Cancer Prevention Program, Moores UCSD Cancer Center, University of California, San Diego, CA.
Patterson RE; Cancer Prevention Program, Moores UCSD Cancer Center, University of California, San Diego, CA.
Pierce JP; Cancer Prevention Program, Moores UCSD Cancer Center, University of California, San Diego, CA.
Caan BJ; Division of Research, Kaiser Permanente Northern California, Oakland, CA.
Ou Shu X; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center; and Vanderbilt-Ingram Cancer Center, Vanderbilt School of Medicine, Nashville, TN.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2016 May 01; Vol. 138 (9), pp. 2088-97. Date of Electronic Publication: 2015 Dec 09.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Life Style*
Breast Neoplasms/*mortality
Breast Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Disease Progression ; Female ; Humans ; Middle Aged ; Neoplasm Recurrence, Local/epidemiology ; Proportional Hazards Models ; Receptors, Estrogen/biosynthesis ; Risk Factors ; Survivors ; Young Adult
Czasopismo naukowe
Tytuł :
Curcumin inhibits LPA-induced invasion by attenuating RhoA/ROCK/MMPs pathway in MCF7 breast cancer cells.
Autorzy :
Sun K; The Second Department of Thoracic Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, China.
Duan X; Department of Nuclear Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Cai H; The Second Department of Thoracic Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, China.; Department of Anesthesia, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Liu X; Department of General Surgery, Second Affiliated Hospital of Lanzhou University, Lanzhou, Gansu, China.
Yang Y; The Second Department of Thoracic Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, China.
Li M; The Second Department of Thoracic Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, China.
Zhang X; Department of Pathology, Lanzhou University Medical School, Lanzhou, Gansu, China.
Wang J; The Second Department of Thoracic Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, China. .
Pokaż więcej
Źródło :
Clinical and experimental medicine [Clin Exp Med] 2016 Feb; Vol. 16 (1), pp. 37-47. Date of Electronic Publication: 2015 Jan 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents/*pharmacology
Breast Neoplasms/*metabolism
Curcumin/*pharmacology
Lysophospholipids/*adverse effects
Signal Transduction/*drug effects
Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Cell Movement/drug effects ; Cell Proliferation/drug effects ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; MCF-7 Cells ; Matrix Metalloproteinases/genetics ; Matrix Metalloproteinases/metabolism ; Neoplasm Invasiveness ; rho-Associated Kinases/genetics ; rho-Associated Kinases/metabolism ; rhoA GTP-Binding Protein/genetics ; rhoA GTP-Binding Protein/metabolism
Czasopismo naukowe
Tytuł :
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
Autorzy :
Meeks HD
Song H
Michailidou K
Bolla MK
Dennis J
Wang Q
Barrowdale D
Frost D
McGuffog L
Ellis S
Feng B
Buys SS
Hopper JL
Southey MC
Tesoriero A
James PA
Bruinsma F
Campbell IG
Broeks A
Schmidt MK
Hogervorst FB
Beckman MW
Fasching PA
Fletcher O
Johnson N
Sawyer EJ
Riboli E
Banerjee S
Menon U
Tomlinson I
Burwinkel B
Hamann U
Marme F
Rudolph A
Janavicius R
Tihomirova L
Tung N
Garber J
Cramer D
Terry KL
Poole EM
Tworoger SS
Dorfling CM
van Rensburg EJ
Godwin AK
Guénel P
Truong T
Stoppa-Lyonnet D
Damiola F
Mazoyer S
Sinilnikova OM
Isaacs C
Maugard C
Bojesen SE
Flyger H
Gerdes AM
Hansen TV
Jensen A
Kjaer SK
Hogdall C
Hogdall E
Pedersen IS
Thomassen M
Benitez J
González-Neira A
Osorio A
Hoya Mde L
Segura PP
Diez O
Lazaro C
Brunet J
Anton-Culver H
Eunjung L
John EM
Neuhausen SL
Ding YC
Castillo D
Weitzel JN
Ganz PA
Nussbaum RL
Chan SB
Karlan BY
Lester J
Wu A
Gayther S
Ramus SJ
Sieh W
Whittermore AS
Monteiro AN
Phelan CM
Terry MB
Piedmonte M
Offit K
Robson M
Levine D
Moysich KB
Cannioto R
Olson SH
Daly MB
Nathanson KL
Domchek SM
Lu KH
Liang D
Hildebrant MA
Ness R
Modugno F
Pearce L
Goodman MT
Thompson PJ
Brenner H
Butterbach K
Meindl A
Hahnen E
Wappenschmidt B
Brauch H
Brüning T
Blomqvist C
Khan S
Nevanlinna H
Pelttari LM
Aittomäki K
Butzow R
Bogdanova NV
Dörk T
Lindblom A
Margolin S
Rantala J
Kosma VM
Mannermaa A
Lambrechts D
Neven P
Claes KB
Maerken TV
Chang-Claude J
Flesch-Janys D
Heitz F
Varon-Mateeva R
Peterlongo P
Radice P
Viel A
Barile M
Peissel B
Manoukian S
Montagna M
Oliani C
Peixoto A
Teixeira MR
Collavoli A
Hallberg E
Olson JE
Goode EL
Hart SN
Shimelis H
Cunningham JM
Giles GG
Milne RL
Healey S
Tucker K
Haiman CA
Henderson BE
Goldberg MS
Tischkowitz M
Simard J
Soucy P
Eccles DM
Le N
Borresen-Dale AL
Kristensen V
Salvesen HB
Bjorge L
Bandera EV
Risch H
Zheng W
Beeghly-Fadiel A
Cai H
Pylkäs K
Tollenaar RA
Ouweland AM
Andrulis IL
Knight JA
Narod S
Devilee P
Winqvist R
Figueroa J
Greene MH
Mai PL
Loud JT
García-Closas M
Schoemaker MJ
Czene K
Darabi H
McNeish I
Siddiquil N
Glasspool R
Kwong A
Park SK
Teo SH
Yoon SY
Matsuo K
Hosono S
Woo YL
Gao YT
Foretova L
Singer CF
Rappaport-Feurhauser C
Friedman E
Laitman Y
Rennert G
Imyanitov EN
Hulick PJ
Olopade OI
Senter L
Olah E
Doherty JA
Schildkraut J
Koppert LB
Kiemeney LA
Massuger LF
Cook LS
Pejovic T
Li J
Borg A
Öfverholm A
Rossing MA
Wentzensen N
Henriksson K
Cox A
Cross SS
Pasini BJ
Shah M
Kabisch M
Torres D
Jakubowska A
Lubinski J
Gronwald J
Agnarsson BA
Kupryjanczyk J
Moes-Sosnowska J
Fostira F
Konstantopoulou I
Slager S
Jones M
Antoniou AC
Berchuck A
Swerdlow A
Chenevix-Trench G
Dunning AM
Pharoah PD
Hall P
Easton DF
Couch FJ
Spurdle AB
Goldgar DE
Pokaż więcej
Corporate Authors :
EMBRACE
kConFab Investigators
Australia Ovarian Cancer Study Group
HEBON
GEMO Study Collaborators
OCGN
PRostate cancer AssoCiation group To Investigate Cancer Associated aLterations in the genome
Źródło :
Journal of the National Cancer Institute [J Natl Cancer Inst] 2015 Nov 19; Vol. 108 (2). Date of Electronic Publication: 2015 Nov 19 (Print Publication: 2016).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Codon, Terminator*
Polymorphism, Single Nucleotide*
BRCA2 Protein/*genetics
Breast Neoplasms/*genetics
Ovarian Neoplasms/*genetics
Prostatic Neoplasms/*genetics
Adult ; Aged ; Female ; Genetic Predisposition to Disease ; Heterozygote ; Humans ; Logistic Models ; Lysine/genetics ; Male ; Middle Aged ; Neoplasm Invasiveness ; Odds Ratio ; Ovarian Neoplasms/pathology ; Risk Assessment ; Risk Factors
Czasopismo naukowe
Tytuł :
Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.
Autorzy :
Guo X; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
Long J; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
Zeng C; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Ghoussaini M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Milne RL; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia. Centre for Epidemiology and Biostatistics, School of Population and Global health, The University of Melbourne, Melbourne, Victoria, Australia.
Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
Cai Q; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
Beesley J; Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Kar SP; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Andrulis IL; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada. Department of Molecular Genetics, University of Toronto, Toronto, Canada.
Anton-Culver H; Department of Epidemiology, University of California Irvine, Irvine, California.
Arndt V; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.
Beckmann MW; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Beeghly-Fadiel A; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
Benitez J; Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain. Centro de Investigación en Red de Enfermedades Raras, Valencia, Spain.
Blot W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. International Epidemiology Institute, Rockville, Maryland.
Bogdanova N; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
Bojesen SE; Copenhagen General Population Study, Herlev Hospital, Herlev, Denmark. Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark. Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Brauch H; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. University of Tübingen, Tübingen, Germany. German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany.
Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany. German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany. Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Brinton L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
Broeks A; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Brüning T; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Bochum, Germany.
Burwinkel B; Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany. Molecular Epidemiology Group, German Cancer Research Center, Heidelberg, Germany.
Cai H; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
Canisius S; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
Choi JY; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Cox A; Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, United Kingdom.
Cross SS; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Darabi H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Devilee P; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands. Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Droit A; Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec, Canada.
Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Fasching PA; Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany. David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California.
Fletcher O; Division of Cancer Studies, Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, United Kingdom.
Flyger H; Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.
Fostira F; Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research 'Demokritos', Athens, Greece.
Gaborieau V; International Agency for Research on Cancer, Lyon, France.
García-Closas M; Division of Cancer Studies, Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, United Kingdom. Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom.
Giles GG; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia. Centre for Epidemiology and Biostatistics, School of Population and Global health, The University of Melbourne, Melbourne, Victoria, Australia.
Grip M; Department of Surgery, Oulu University Hospital and University of Oulu, Oulu, Finland.
Guénel P; Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif, France. University Paris-Sud, Villejuif, France.
Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany.
Hartman M; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore. Department of Surgery, National University Health System, Singapore.
Hollestelle A; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Hopper JL; Centre for Epidemiology and Biostatistics, School of Population and Global health, The University of Melbourne, Melbourne, Victoria, Australia.
Hsiung CN; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Ito H; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Aichi, Japan.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Johnson N; Division of Cancer Studies, Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, United Kingdom.
Kabisch M; Molecular Genetics of Breast Cancer, German Cancer Research Center, Heidelberg, Germany.
Kang D; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Khan S; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
Knight JA; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Kosma VM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
Lambrechts D; Vesalius Research Center, Leuven, Belgium. Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
Le Marchand L; University of Hawaii Cancer Center, Honolulu, Hawaii.
Li J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Lophatananon A; Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, United Kingdom.
Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Mannermaa A; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland; Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
Manoukian S; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
Margolin S; Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden.
Marme F; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany. Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
Matsuo K; Department of Preventive Medicine, Kyushu University Faculty of Medical Sciences, Fukuoka, Japan.
McLean CA; Anatomical Pathology, The Alfred Hospital, Melbourne, Victoria, Australia.
Meindl A; Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany.
Muir K; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy. Institute of Population Health, University of Manchester, Manchester, United Kingdom.
Neuhausen SL; Beckman Research Institute of City of Hope, Duarte, California.
Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.
Nord S; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Ullernchausseen, Oslo, Norway. K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Kirkeveien, Oslo, Norway.
Olson JE; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Orr N; Division of Breast Cancer Research, Institute of Cancer Research, London, United Kingdom; Cancer Research, Institute of Cancer Research, London, United Kingdom.
Peterlongo P; IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Putti TC; Department of Pathology, National University Health System, Singapore.
Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
Sangrajrang S; National Cancer Institute, Bangkok, Thailand.
Sawyer EJ; Research Oncology, Guy's Hospital, King's College London, London, United Kingdom.
Schmidt MK; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Schmutzler RK; Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, Cologne, Germany. Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany. Center for Molecular Medicine, University Hospital of Cologne, Cologne, Germany. Center of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
Shen CY; School of Public Health, China Medical University, Taichung, Taiwan. Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Shi J; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
Shrubsole MJ; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
Southey MC; Department of Pathology, The University of Melbourne, Melbourne, Victoria, Australia.
Swerdlow A; Division of Genetics and Epidemiology and Division of Breast Cancer Research, Institute of Cancer Research, London, United Kingdom.
Teo SH; Cancer Research Initiatives Foundation, Subang Jaya, Selangor, Malaysia. Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Thienpont B; Vesalius Research Center, Leuven, Belgium. Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
Toland AE; Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Tollenaar RA; Department of Surgical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
Tomlinson IP; Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
Truong T; Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif, France. University Paris-Sud, Villejuif, France.
Tseng CC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
van den Ouweland A; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands.
Wen W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry, University of Oulu, Oulu, Finland. Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre NordLab, Oulu, Finland.
Wu A; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
Yip CH; Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Zamora MP; Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain.
Zheng Y; Shanghai Municipal Center for Disease Control and Prevention, Shanghai, PR China.
Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Pharoah PD; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Simard J; Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec, Canada.
Chenevix-Trench G; Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. .
Pokaż więcej
Corporate Authors :
kConFab Investigators
Źródło :
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2015 Nov; Vol. 24 (11), pp. 1680-91. Date of Electronic Publication: 2015 Sep 09.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Chromosome Mapping*
Breast Neoplasms/*genetics
Chromosomes, Human, Pair 4/*genetics
Genetic Predisposition to Disease/*genetics
Breast Neoplasms/etiology ; Case-Control Studies ; Female ; Genetic Loci/genetics ; Genetic Markers/genetics ; Genome-Wide Association Study ; Humans ; Logistic Models ; Polymorphism, Single Nucleotide/genetics ; Risk Factors
Czasopismo naukowe
Tytuł :
Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
Autorzy :
Orr N; The Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research and .
Dudbridge F; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Dryden N; The Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research and.
Maguire S; The Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research and.
Novo D; The Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research and.
Perrakis E; The Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research and.
Johnson N; The Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research and.
Ghoussaini M; Centre for Cancer Genetic Epidemiology, Department of Oncology and.
Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health and.
Southey MC; Department of Pathology, The University of Melbourne, Melbourne, VIC 3010, Australia.
Apicella C; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health and.
Stone J; Centre for Genetic Origins of Health and Disease, University of Western Australia, Perth, WA, Australia.
Schmidt MK; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.
Broeks A; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.
Van't Veer LJ; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.
Hogervorst FB; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.
Fasching PA; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen and David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Haeberle L; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen and.
Ekici AB; Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany.
Beckmann MW; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen and.
Gibson L; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Aitken Z; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Warren H; Department of Clinical Pharmacology, William Harvey Research Institute, Barts and The London School of Medicine and NIHR Barts Cardiovascular Biomedical Research Unit, Queen Mary University of London, London, UK.
Sawyer E; Division of Cancer Studies, Kings College London, Guy's Hospital, London, UK.
Tomlinson I; Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, UK.
Kerin MJ; Clinical Science Institute, University Hospital Galway, Galway, Ireland.
Miller N; Clinical Science Institute, University Hospital Galway, Galway, Ireland.
Burwinkel B; Department of Obstetrics and Gynecology and Molecular Epidemiology Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Marme F; Department of Obstetrics and Gynecology and National Center for Tumor Diseases, University of Heidelberg, 69120 Heidelberg, Germany.
Schneeweiss A; Department of Obstetrics and Gynecology and National Center for Tumor Diseases, University of Heidelberg, 69120 Heidelberg, Germany.
Sohn C; Department of Obstetrics and Gynecology and.
Guénel P; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France, University Paris-Sud, UMRS 1018, Villejuif, France.
Truong T; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France, University Paris-Sud, UMRS 1018, Villejuif, France.
Cordina-Duverger E; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France, University Paris-Sud, UMRS 1018, Villejuif, France.
Sanchez M; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France, University Paris-Sud, UMRS 1018, Villejuif, France.
Bojesen SE; Copenhagen General Population Study and Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.
Nordestgaard BG; Copenhagen General Population Study and Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.
Nielsen SF; Copenhagen General Population Study and Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.
Flyger H; Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
Benitez J; Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain, Centro de Investigación en Red de Enfermedades Raras (CIBERER), 46010 Valencia, Spain.
Zamora MP; Servicio de Oncología Médica, Hospital Universitario La Paz, 28046 Madrid, Spain.
Arias Perez JI; Servicio de Cirugía General y Especialidades and.
Menéndez P; Servicio de Anatomía Patológica, Hospital Monte Naranco, 33012 Oviedo, Spain.
Anton-Culver H; Department of Epidemiology, University of California Irvine, Irvine, CA, USA.
Neuhausen SL; Beckman Research Institute of City of Hope, Duarte, CA, USA.
Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Consortium (DKTK).
Dieffenbach AK; Division of Clinical Epidemiology and Aging Research, German Cancer Consortium (DKTK).
Arndt V; Division of Clinical Epidemiology and Aging Research.
Stegmaier C; Saarland Cancer Registry, Saarbrücken, Germany.
Hamann U; Molecular Genetics of Breast Cancer and.
Brauch H; German Cancer Consortium (DKTK), Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany, University of Tübingen, Tübingen, Germany.
Justenhoven C; Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany, University of Tübingen, Tübingen, Germany.
Brüning T; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-University Bochum (IPA), Bochum, Germany.
Ko YD
Nevanlinna H; Department of Obstetrics and Gynecology.
Aittomäki K; Department of Clinical Genetics and.
Blomqvist C; Department of Oncology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Khan S; Department of Obstetrics and Gynecology.
Bogdanova N; Department of Radiation Oncology and Department of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany.
Dörk T; Department of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany.
Lindblom A; Department of Molecular Medicine and Surgery and.
Margolin S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Mannermaa A; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Imaging Center, Department of Clinical Pathology and.
Kataja V; School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, Kuopio, Finland, Biocenter Kuopio, Cancer Center of Eastern Finland, Kuopio University Hospital, Kuopio, Finland, Central Finland Health Care District, Jyväskylä Central Hospital, Jyväskylä, Finland.
Kosma VM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Imaging Center, Department of Clinical Pathology and.
Hartikainen JM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine and Imaging Center, Department of Clinical Pathology and.
Chenevix-Trench G; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Beesley J
Lambrechts D; Vesalius Research Center (VRC), VIB, Leuven, Belgium, Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
Moisse M; Vesalius Research Center (VRC), VIB, Leuven, Belgium, Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
Floris G; University Hospital Gasthuisberg, Leuven, Belgium.
Beuselinck B; University Hospital Gasthuisberg, Leuven, Belgium.
Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Seibold P; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Flesch-Janys D; Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany.
Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine and.
Peterlongo P; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy.
Peissel B; Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
Pensotti V; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy, Cogentech Cancer Genetic Test Laboratory, Milan, Italy.
Couch FJ; Department of Laboratory Medicine and Pathology and.
Olson JE; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Slettedahl S; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Vachon C; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Giles GG; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health and Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia.
Milne RL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health and Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia.
McLean C; Anatomical Pathology, The Alfred Hospital, Melbourne, VIC, Australia.
Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Henderson BE; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Schumacher F; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Le Marchand L; Epidemiology Program, Cancer Research Center, University of Hawaii, Honolulu, HI, USA.
Simard J; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, QC, Canada.
Goldberg MS; Department of Medicine, McGill University, Montreal, QC, Canada, Division of Clinical Epidemiology, McGill University Health Centre, Royal Victoria Hospital, Montreal, QC, Canada.
Labrèche F; Département de Médecine Sociale et Préventive, Département de Santé Environnementale et Santé au travail, Université de Montréal, Montreal, QC, Canada.
Dumont M; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, QC, Canada.
Kristensen V; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, N-0310 Oslo, Norway, Institute of Clinical Medicine, University of Oslo (UiO), 0450 Oslo, Norway.
Alnæs GG; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, N-0310 Oslo, Norway.
Nord S; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, N-0310 Oslo, Norway.
Borresen-Dale AL; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, N-0310 Oslo, Norway, Institute of Clinical Medicine, University of Oslo (UiO), 0450 Oslo, Norway.
Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Deming-Halverson S; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Shrubsole M; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Long J; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Genetics and Biocenter Oulu.
Pylkäs K; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Genetics and Biocenter Oulu.
Jukkola-Vuorinen A; Department of Oncology and.
Grip M; Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland.
Andrulis IL; Ontario Cancer Genetics Network and Department of Molecular Genetics and.
Knight JA; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada, Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Glendon G; Ontario Cancer Genetics Network and.
Tchatchou S; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.
Devilee P; Department of Human Genetics and Department of Pathology and.
Tollenaar RA; Department of Surgical Oncology, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.
Seynaeve CM; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.
Garcia-Closas M; The Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research and Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Figueroa J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Lissowska J; Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center & Institute of Oncology, Warsaw, Poland.
Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden.
Darabi H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden.
Eriksson M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden.
Klevebring D; Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center & Institute of Oncology, Warsaw, Poland.
Hooning MJ; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Hollestelle A; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
van Deurzen CH; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Kriege M; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden.
Li J; Human Genetics Division, Genome Institute of Singapore, Singapore 138672, Singapore.
Liu J; Human Genetics Division, Genome Institute of Singapore, Singapore 138672, Singapore.
Humphreys K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden.
Cox A; Sheffield Cancer Research, Department of Oncology, University of Sheffield, Sheffield, UK.
Cross SS; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK.
Reed MW; Brighton and Sussex Medical School, University of Sussex, Brighton, East Sussex, UK.
Pharoah PD; Centre for Cancer Genetic Epidemiology, Department of Oncology and.
Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology and.
Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology and.
Perkins BJ; Centre for Cancer Genetic Epidemiology, Department of Oncology and.
Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, 70-115 Szczecin, Poland.
Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, 70-115 Szczecin, Poland.
Jaworska-Bieniek K; Department of Genetics and Pathology, Pomeranian Medical University, 70-115 Szczecin, Poland.
Durda K; Department of Genetics and Pathology, Pomeranian Medical University, 70-115 Szczecin, Poland.
Ashworth A; The Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research and.
Swerdlow A; Division of Breast Cancer Research and Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Jones M; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Schoemaker MJ; Division of Breast Cancer Research and Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Meindl A; Division of Gynaecology and Obstetrics, Technische Universität München, 81675 Munich, Germany.
Schmutzler RK; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO) and Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany.
Olswold C; Department of Laboratory Medicine and Pathology and.
Slager S; Department of Laboratory Medicine and Pathology and.
Toland AE; Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Yannoukakos D; Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research 'Demokritos', Aghia Paraskevi Attikis, Athens, Greece.
Muir K; Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, UK, Institute of Population Health, University of Manchester, Manchester, UK.
Lophatananon A; Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, UK.
Stewart-Brown S; Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, UK.
Siriwanarangsan P; Ministry of Public Health, Nonthaburi, Thailand.
Matsuo K; Department of Preventive Medicine, Kyushu University Faculty of Medical Sciences, Fukuoka, Japan.
Ito H; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Ishiguro J; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Tseng CC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Van Den Berg D; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Stram DO; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Teo SH; Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Selangor, Malaysia, Breast Cancer Research Unit, University Malaya Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Yip CH; Breast Cancer Research Unit, University Malaya Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Kang P; Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Selangor, Malaysia.
Ikram MK; Singapore Eye Research Institute, National University of Singapore, 168751 Singapore, Singapore.
Shu XO; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Lu W; Shanghai Center for Disease Control and Prevention, Shanghai, China.
Gao YT; Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China.
Cai H; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Kang D; Department of Preventive Medicine and Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea, Cancer Research Institute, Seoul National University, Seoul, Korea.
Choi JY; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea, Cancer Research Institute, Seoul National University, Seoul, Korea.
Park SK; Department of Preventive Medicine and Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea, Cancer Research Institute, Seoul National University, Seoul, Korea.
Noh DY; Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
Hartman M; Saw Swee Hock School of Public Health and Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, National University Health System, Singapore, Singapore.
Miao H; Saw Swee Hock School of Public Health and National University Health System, Singapore, Singapore.
Lim WY; Saw Swee Hock School of Public Health and National University Health System, Singapore, Singapore.
Lee SC; Department of Haematology-Oncology, National University Health System, Singapore, Singapore, Cancer Science Institute of Singapore, National University Singapore, Singapore, Singapore.
Sangrajrang S; National Cancer Institute, Bangkok, Thailand.
Gaborieau V; International Agency for Research on Cancer, Lyon, France.
Brennan P; International Agency for Research on Cancer, Lyon, France.
Mckay J; International Agency for Research on Cancer, Lyon, France.
Wu PE; Taiwan Biobank and Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
Hou MF; Cancer Center and Department of Surgery, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung 804, Taiwan.
Yu JC; Department of Surgery, Tri-Service General Hospital and National Defense Medical Center, Taipei 114, Taiwan.
Shen CY; Cancer Center and Department of Surgery, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung 804, Taiwan, School of Public Health, China Medical University, Taichung 404, Taiwan.
Blot W; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA, International Epidemiology Institute, Rockville, MD, USA.
Cai Q; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Signorello LB; Dana-Farber/Harvard Cancer Center, Boston, MA, USA, Department of Epidemiology and.
Luccarini C; Centre for Cancer Genetic Epidemiology, Department of Oncology and.
Bayes C; Centre for Cancer Genetic Epidemiology, Department of Oncology and.
Ahmed S; Centre for Cancer Genetic Epidemiology, Department of Oncology and.
Maranian M; Centre for Cancer Genetic Epidemiology, Department of Oncology and.
Healey CS; Centre for Cancer Genetic Epidemiology, Department of Oncology and.
González-Neira A; Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain and.
Pita G; Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain and.
Alonso MR; Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain and.
Álvarez N; Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain and.
Herrero D; Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain and.
Tessier DC; Centre d'innovation Génome Québec et Université McGill, Montréal, QC, Canada.
Vincent D; Centre d'innovation Génome Québec et Université McGill, Montréal, QC, Canada.
Bacot F; Centre d'innovation Génome Québec et Université McGill, Montréal, QC, Canada.
Hunter DJ; Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, MA, USA.
Lindstrom S; Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, MA, USA.
Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Easton DF; Centre for Cancer Genetic Epidemiology, Department of Oncology and Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
dos Santos Silva I; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Fletcher O; The Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research and.
Peto J; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Pokaż więcej
Corporate Authors :
GENICA Network
kConFab Investigators
Australian Ovarian Cancer Study Group
Źródło :
Human molecular genetics [Hum Mol Genet] 2015 May 15; Vol. 24 (10), pp. 2966-84. Date of Electronic Publication: 2015 Feb 04.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Chromosomes, Human, Pair 9*
Genetic Loci*
Genetic Predisposition to Disease*
Polymorphism, Single Nucleotide*
Breast Neoplasms/*genetics
Adult ; Aged ; Asian Continental Ancestry Group/genetics ; Chromosome Mapping ; Enhancer Elements, Genetic ; Estrogen Receptor alpha/genetics ; European Continental Ancestry Group/genetics ; Female ; GATA3 Transcription Factor/genetics ; Genetic Association Studies ; Hepatocyte Nuclear Factor 3-alpha/genetics ; Humans ; Kruppel-Like Transcription Factors/genetics ; Middle Aged ; Risk
Czasopismo naukowe
Tytuł :
Soy isoflavone intake and bone mineral density in breast cancer survivors.
Autorzy :
Baglia ML; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, 37203, USA.
Gu K
Zhang X
Zheng Y
Peng P
Cai H
Bao PP
Zheng W
Lu W
Shu XO
Pokaż więcej
Źródło :
Cancer causes & control : CCC [Cancer Causes Control] 2015 Apr; Vol. 26 (4), pp. 571-80. Date of Electronic Publication: 2015 Feb 17.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Bone Density/*physiology
Breast Neoplasms/*pathology
Isoflavones/*administration & dosage
Phytoestrogens/*administration & dosage
Absorptiometry, Photon ; Adult ; Aged ; China ; Female ; Humans ; Menopause ; Middle Aged ; Prospective Studies ; Soy Foods ; Survivors
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies